Baltimore, Maryland
The David Goldfarb, MD Professor of Surgery
The Johns Hopkins University School of Medicine
Chief and Regional Director of Vascular Surgery and Endovascular Therapy
The Johns Hopkins Hospital and Johns Hopkins Medicine
SCHEDULE FOR VEITHsymposium™
Tuesday, November 16, 2021
Session Moderator
SESSION-3: PROGRESS IN THE ENDOVASCULAR TREATMENT OF AORTIC DISSECTIONS: REPORTING STANDARDS, CLASSIFICATION SYSTEMS, STABILISE, AND MORE
Presenter
SESSION 3: PROGRESS IN THE ENDOVASCULAR TREATMENT OF AORTIC DISSECTIONS: REPORTING STANDARDS, CLASSIFICATION SYSTEMS, STABILISE, AND MORE
When Is TEVAR The Best Treatment For Marfan Syndrome And Its Complications
8:44 AM - 8:49 AM

View Slides in PDF
Presenter
SESSION 18: VASCULAR SURGERY’S NUMBERS, IDENTITY, RECOGNITION, INDEPENDENT SPECIALTY STATUS; HOW TO INCREASE OUR NUMBERS TO MEET FUTURE NEEDS FOR OUR SERVICES
Why US News & World Report Cannot And Does Not Rank Vascular Surgery Programs: Vascular Surgery Needs To Be An Independent ABMS Approved Specialty: Why Isn’t It
2:12 PM - 2:17 PM

View Slides in PDF
Friday, November 19, 2021
Session Moderator
SESSION-87: NEW DEVELOPMENTS IN MEDICAL AND DRUG TREATMENTS: BEST ANTIPLATELET REGIMENS; UPDATE ON RARE VASCULAR DISEASES
Presenter
SESSION 87: NEW DEVELOPMENTS IN MEDICAL AND DRUG TREATMENTS: BEST ANTIPLATELET REGIMENS; UPDATE ON RARE VASCULAR DISEASES
How To Make Operations For Complications Of Vascular Ehlers Danlos Syndrome Go Well
3:36 PM - 3:41 PM

View Slides in PDF
 
previous next